| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/05/2009 | EP2083852A1 Tumor immunity |
| 08/05/2009 | EP2083837A1 Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent |
| 08/05/2009 | EP2083830A1 Improved methods of using phosphoantigen for the treatment of cancer |
| 08/05/2009 | EP2083821A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 08/05/2009 | EP2012801A4 Gemcitabine combination therapy |
| 08/05/2009 | EP2006302A9 Protein complex and process for production thereof |
| 08/05/2009 | EP1877398B1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 08/05/2009 | EP1877397B1 Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1663340B1 Catheter balloon systems |
| 08/05/2009 | EP1660507B1 Proteasome inhibitors and methods of using the same |
| 08/05/2009 | EP1641457B1 Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| 08/05/2009 | EP1631292B1 4-anilino-quinazoline derivatives as antiproliferative agents |
| 08/05/2009 | EP1560837B1 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 08/05/2009 | EP1531803A4 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1491534B1 Novel hairpin polyamide |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1253939B1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 08/05/2009 | EP1235595B1 Integrin-mediated drug targeting |
| 08/05/2009 | EP1210115B1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/05/2009 | CN101501108A Micelles for drug delivery |
| 08/05/2009 | CN101501070A Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 08/05/2009 | CN101501069A Protein complex and process for production thereof |
| 08/05/2009 | CN101501038A Fused [d]pyridazin-7-ones |
| 08/05/2009 | CN101501035A Pyrimidine derivative as P13K inhibitor and use thereof |
| 08/05/2009 | CN101501030A Pyrimidine derivatives useful in the treatment of cancer |
| 08/05/2009 | CN101501026A Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
| 08/05/2009 | CN101501023A Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 08/05/2009 | CN101501022A Benzimidazole derivatives which are to be used as anatgonis for the CB1-receptor |
| 08/05/2009 | CN101501004A Compounds and compositions as HEDGEHOG signaling pathway modulators |
| 08/05/2009 | CN101500613A A novel lactic acid formulation of MK-0457 useful for the treatment of cancer |
| 08/05/2009 | CN101500609A Hematopoietic stem cell proliferation promoter |
| 08/05/2009 | CN101500604A Plasmids with immunological action |
| 08/05/2009 | CN101500571A Stable lyophilized preparation |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN101500562A Thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 08/05/2009 | CN101497922A Use of PNMA5 gene |
| 08/05/2009 | CN101497887A Efficient and stable expression, purification and use of recombinant snake poison metal protease Jerdonitin |
| 08/05/2009 | CN101497886A Polypeptide of fungal thioredoxin, coding sequence, preparation and use |
| 08/05/2009 | CN101497878A Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use |
| 08/05/2009 | CN101497876A Recombinant adenovirus for expressing targetedly proliferating recombinant adenovirus for expressing proapoptosis gene and use thereof |
| 08/05/2009 | CN101497666A Double specificity oligopeptide-cefuroxime sodium strengthened fusion protein Ec-LDP-Hr-AE |
| 08/05/2009 | CN101497662A TM4SF3 protein for preparing antineoplastic antibody and use thereof |
| 08/05/2009 | CN101497656A Polypeptide with high combination activity with integrin alpha v beta 3 and use thereof |
| 08/05/2009 | CN101497653A Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN101497652A Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN101497641A Method for synthesizing delta 24(28) cholesterol compounds |
| 08/05/2009 | CN101497640A Novel crystal form of clofarabine |
| 08/05/2009 | CN101497611A N-(3-carboxyl-9-benzyl carboline-1-yl) ethyl amino acid, as well as synthesizing method and use thereof |
| 08/05/2009 | CN101497608A HIV protease inhibitor derivative, preparation thereof and use in antineoplastic medicament preparation |
| 08/05/2009 | CN101497600A 2,4,5- tri-substituted-1,3-dithiolane, synthesizing method and use thereof |
| 08/05/2009 | CN101497593A 5-hydroxy coumarin and pyranoid type coumarin compounds, synthesizing method and use |
| 08/05/2009 | CN101497590A 13-alkoxy-3,15-dioxo-gibberellic acid ester and preparation thereof |
| 08/05/2009 | CN101497584A Isoquinoline-3-formyl amino acid formyl amino acid benzyl ester, as well as preparation and use thereof |
| 08/05/2009 | CN101497568A Use of Sichuang-Tibet amethystoidin A in preventing and treating acute lymphocyte leukaemia and cervical cancer |
| 08/05/2009 | CN101497567A Preparation of 3-(3,4-dihydroxyphenyl)-acrylic acid 2-(3,4-dihydroxyphenyl)-ethyl ester and derivative phenyl acrylic acid phenyl alkyl ester compound |
| 08/05/2009 | CN101496885A Chinese herbal medicine preparation for treating tumor |
| 08/05/2009 | CN101496884A Capsule for treating gastric precancerous lesion |
| 08/05/2009 | CN101496851A Chinese medicine for treating carcinous pleural fluid and ascites |
| 08/05/2009 | CN101496845A Hedyotis diffusa Willd. extract and method for separating and preparing the same |
| 08/05/2009 | CN101496827A Application of pumpkin protein in preparing medicament for treating chronic myeloid leukemia |
| 08/05/2009 | CN101496825A Oleum fructus bruceae preparation and preparation method thereof |
| 08/05/2009 | CN101496819A Eubacterium, Clostridium preparation and use thereof |
| 08/05/2009 | CN101496817A Application of clam active polypeptide in preparing anti-lung cancer medicament |
| 08/05/2009 | CN101496805A Application of 4-acetyl diazene quinoline derivatives in preparing anti-tumor medicament |
| 08/05/2009 | CN101496804A Composition containing tripterine, preparation method and use |
| 08/05/2009 | CN101496579A Special diet and foodstuffs formula containing small peptide for tumor patient |
| 08/05/2009 | CN100523215C RNA interference mediating small RNA molecules |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100523186C Sequence against human esophagus cancer invasion and transfer |
| 08/05/2009 | CN100522995C Cell wall acyl-alanyl-D-isoglutamine derivative and its preparation, medicine composition and use |
| 08/05/2009 | CN100522994C Discrimination between GnRH-I and GnRH-II |
| 08/05/2009 | CN100522992C Novel ring-shape small-peptide BA and its use |
| 08/05/2009 | CN100522987C Saponins antineoplastic compound in Bohadschia argus Jaeger |
| 08/05/2009 | CN100522968C A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522956C Substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 08/05/2009 | CN100522955C Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 08/05/2009 | CN100522949C Piperazinedione compounds |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/05/2009 | CN100522910C Fluorocombretastatin and derivatives thereof |
| 08/05/2009 | CN100522250C N type non-viral vector and pharmaceutical composition containing same |
| 08/05/2009 | CN100522249C Elogated and multiple spacers in activatible prodrugs |
| 08/05/2009 | CN100522239C Pharmaceutical formulations for sustained drug delivery |
| 08/05/2009 | CN100522237C Anticancer soft capsule and its preparation process |
| 08/05/2009 | CN100522220C Oral medicine for treating breast cancer |
| 08/05/2009 | CN100522184C Extract with anti-tumor and anti-poisonous activity |
| 08/05/2009 | CN100522173C Pharmaceutical composition containing pemetrexed |
| 08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
| 08/05/2009 | CN100522154C Use of isothiocyanates compound for treatment of helicobacter |
| 08/05/2009 | CN100522153C Application of carbonyl scavengers for preparing medicament for inducing or increasing cell death |